Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative drugs operate by mimicking the natural actions of GLP-1, a hormone produced by the gut in https://adamozcg346668.ja-blog.com/39241149/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes